Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Key failure to deliver metrics for Bausch Health
:
Last SEC data release: 2024-03-28
Last 15 days FTD volume: $0.07 M
Last 3 months FTD volume: $3.96 M
Last year FTD volume: $34.92 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Bausch Health
(BHC) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Bausch Health
(BHC) - since 2018
Volume in USD (price x number of shares), data since 2018
Bausch Health
(BHC) Failure to deliver volume, Year over Year
Year
Volume (Price x Shares)
Change
2024
$3.95 M
-91.91%
2023
$48.92 M
-67.42%
2022
$0.15 B
134.23%
2021
$64.09 M
-45.29%
2020
$0.11 B
13.03%
2019
$0.10 B
100.86%
2018
$51.6 M
FTD volume in the last 3 months for similar companies or competitors